The Effect of Biological Effective Dose on Time to Symptom Progression in Metastatic Renal Cell Carcinoma

Author： Wilson D.   Hiller L.   Gray L.   Grainger M.   Stirling A.   James N.  

Publisher： Elsevier

ISSN： 0936-6555

Source： Clinical Oncology, Vol.15, Iss.7, 2003-10, pp. : 400-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah   Larkin James   Pickering Lisa  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Diarrhea as the presenting symptom of renal cell carcinoma

By Chataut Chandra P.     Mullane Michael   Firfer Bourke L.   Shah Binay K.  

Acta Oncologica, Vol. 50, Iss. 5, 2011-06 ,pp. : 732-733

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Factors of Immunotherapy in Metastatic Renal Cell Carcinoma

By Padrik Peeter  

Medical Oncology, Vol. 20, Iss. 4, 2003-12 ,pp. : 325-334

Humana Press, Inc

Access to resources Recommend Favorite

Axitinib in the treatment of metastatic renal cell carcinoma

By Ho Thai H   Jonasch Eric  

Future Oncology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1247-1253

Future Medicine

Access to resources Recommend Favorite

Current Strategy in the Treatment of Metastatic Renal Cell Carcinoma

By  

Current Cancer Therapy Reviews, Vol. 1, Iss. 2, 2005-06 ,pp. : 127-137

Bentham Science Publishers

Access to resources Recommend Favorite